Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass

NCT00775684 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Pre-diabetes
Type 2 Diabetes

Interventions

DRUG: Exenatide
DRUG: Sitagliptin
DRUG: Glimepiride

Sponsor

University of Pennsylvania

Collaborators

[object Object]